日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Influence of ovarian hormones on value-based decision-making systems: Contribution to sexual dimorphisms in mental disorders

MPS-Authors
/persons/resource/persons227460

Lewis,  Carolin Annette
Department for Psychiatry and Psychotherapy, Eberhard Karls University Tübingen, Germany;
Minerva Research Group EGG (Emotion & neuroimaGinG) Lab, MPI for Human Cognitive and Brain Sciences, Max Planck Society;
International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Ambrase, A., Lewis, C. A., Barth, C., & Derntl, B. (2021). Influence of ovarian hormones on value-based decision-making systems: Contribution to sexual dimorphisms in mental disorders. Frontiers in Neuroendocrinology, 60:. doi:10.1016/j.yfrne.2020.100873.


引用: https://hdl.handle.net/21.11116/0000-0007-1F9C-8
要旨
Women and men exhibit differences in behavior when making value-based decisions. Various hypotheses have been proposed to explain these findings, stressing differences in functional lateralization of the brain, functional activation, neurotransmitter involvement and more recently, sex hormones. While a significant interaction of neurotransmitter systems and sex hormones has been shown for both sexes, decision-making in women might be particularly affected by variations of ovarian hormones. In this review we have gathered information from animal and human studies on how ovarian hormones affect decision-making processes in females by interacting with neurotransmitter systems at functionally relevant brain locations and thus modify the computation of decision aspects. We also review previous findings on impaired decision-making in animals and clinical populations with substance use disorder and depression, emphasizing how little we know about the role of ovarian hormones in aberrant decision-making.